RSEFX | SSGSX | RSEFX / SSGSX | |
Total Expense Ratio | 1.49 | 1.26 | 118% |
Annual Report Gross Expense Ratio | 1.57 | 1.26 | 125% |
Fund Existence | 22 years | 26 years | - |
Gain YTD | -14.868 | -15.873 | 94% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 2000 | 2500 | 80% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 478M | 5.23B | 9% |
Annual Yield % from dividends | 2.28 | 0.52 | 443% |
Returns for 1 year | -21.71 | -17.17 | 126% |
Returns for 3 years | -24.00 | -16.99 | 141% |
Returns for 5 years | -4.10 | 14.83 | -28% |
Returns for 10 years | -38.56 | -0.35 | 11,048% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BIPSX | 17.39 | 0.97 | +5.91% |
ProFunds Biotechnology UltraSector Svc | |||
FCIRX | 16.05 | 0.37 | +2.36% |
NYLI PineStone International Equity Cl A | |||
HDGYX | 33.02 | 0.57 | +1.76% |
Hartford Dividend and Growth Y | |||
RSEDX | 15.22 | 0.22 | +1.47% |
Columbia Large Cap Value Inst2 | |||
VRESX | 15.08 | 0.20 | +1.34% |
Virtus KAR Emerging Markets Small-Cap R6 |